MiMedx Group, Inc. Restructuring Reserve
MiMedx Group, Inc. (MDXG) had Restructuring Reserve of $0 as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2023-02-28
- 2021-12-31: Restructuring Reserve $0.00.
- 2020-12-31: Restructuring Reserve $0.00.
- 2019-12-31: Restructuring Reserve $3.56M.
- 2018-12-31: Restructuring Reserve $5.61M.
| Period end | Restructuring Reserve |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2019-12-31 | $3.56M 10-K · filed 2023-02-28 |
| 2018-12-31 | $5.61M 10-K · filed 2021-03-08 |
| 2017-12-31 | $0.00 10-K · filed 2021-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |